Home / Pharmaceutical company intelligence
Neutro Pharma (Pvt.) Ltd., logo
Pharmaceutical company intelligence

Neutro Pharma (Pvt.) Ltd.,

Private pharmaceutical and nutraceutical manufacturer · Lahore · Pakistan

Lahore-based pharmaceutical and wellness company manufacturing pharmaceuticals, nutraceuticals and specialty healthcare products.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation25 Sep 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date4 Aug 2026Newest effective date among published current price records
Corporate profile evidence5 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Legal / official name
Neutro Pharma (Pvt.) Ltd.
Company type
Private pharmaceutical and nutraceutical manufacturer
Address
23-M, Gulberg III, Lahore, Pakistan
Phone
+92 42 37339087-89
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
100%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000576 Neutro Pharma (Pvt) Ltd. · Punjab
Semi Basic Manufacture 000877 Neutro Pharma (Pvt) Ltd. · Punjab
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000576 211 linked products · source seen 25 Sep 2026 View source ↗
Corporate profile source ledger Logo Url source ↗ Contact Page Url source ↗ Logo Source Url source ↗ Profile Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx216public portfolio records represented
REG194unique registrations represented
IDX93indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+0registry-only registrations
VER9registry-verified exact registrations
PKR210current validated price records
G97generic molecules in indexed catalogue
DF12dosage-form groups
TA15therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage97%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage95%
priced packs safely normalized per unit
Comparable-market coverage83%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixNeutro Pharma (Pvt.) Ltd.,Share of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/neutro-pharma-pvt-ltdGenerated 25 Sep 2026Anti-infectives93 · 44%CNS & mental health31 · 15%Fluids & supportive care24 · 11%Oncology & immunology9 · 4%Cross-therapeutic & anti-inflamma…8 · 4%Gastrointestinal & hepatology8 · 4%Vitamins, minerals & nutrition7 · 3%Other therapeutic areas30 · 14%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioNeutro Pharma (Pvt.) Ltd.,Distribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/neutro-pharma-pvt-ltdGenerated 25 Sep 2026210presentationsTablet74 · 35%Injection55 · 26%Capsule24 · 11%Infusion23 · 11%Suspension18 · 9%Cream6 · 3%Other forms10 · 5%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionNeutro Pharma (Pvt.) Ltd.,Current company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/neutro-pharma-pvt-ltdGenerated 25 Sep 2026174comparable productsBelow peer median51 · 29%Near peer median77 · 44%Above peer median46 · 26%Company median price position+0.2%Lowest-price equivalents21Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsNeutro Pharma (Pvt.) Ltd.,Companies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/neutro-pharma-pvt-ltdGenerated 25 Sep 2026Pharmasol (Pvt) Ltd.51 shared53% overlapM/s. Genix Pharma (Pvt) Ltd.50 shared52% overlapBio-Labs(Pvt) Ltd47 shared48% overlapMediate Pharmaceutical Pvt Ltd46 shared47% overlapNabiqasim Industries (Pvt) Ltd.,45 shared46% overlapValor Pharmaceuticals44 shared45% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives93 products · 44%
CNS & mental health31 products · 15%
Fluids & supportive care24 products · 11%
Oncology & immunology9 products · 4%
Cross-therapeutic & anti-inflammatory8 products · 4%
Gastrointestinal & hepatology8 products · 4%
Vitamins, minerals & nutrition7 products · 3%
Dermatology6 products · 3%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Fluids, electrolytes & diluents24 products · 11%
Antivirals18 products · 9%
Third-generation cephalosporins16 products · 8%
Antipsychotics14 products · 7%
Fluoroquinolone antibacterials13 products · 6%
Antimalarials11 products · 5%
Macrolide antibacterials10 products · 5%
Antiepileptics10 products · 5%
Formulation footprint

Dosage forms

Tablet74 products
Injection55 products
Capsule24 products
Infusion23 products
Suspension18 products
Cream6 products
Sachet3 products
Solution2 products
Syrup2 products
Drops1 products
Inhalation1 products
Other1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 NeucludEntecavir 6presentations 0.05 mg/mL, 0.5 mg, 1 mg · Solution, Tablet #2 NlyteDextrose + Sodium chloride 6presentations 3.3% + 0.3%, NaCl 0.3g + Dextrose 3.3g/100 mL, NaCl 0.45g + Dextrose 10g/100 mL, NaCl 0.45g + Dextrose 5.0g/100 mL · Infusion #3 VexaCeftriaxone 6presentations 1 g, 1.0 g, 250 mg, 500 mg · Injection #4 AffifCiprofloxacin 5presentations 125 mg/5 mL, 200 mg, 250 mg, 250 mg/5 mL · Suspension, Infusion, Tablet #5 NeurivoxRivaroxaban 5presentations 10 mg, 15 mg, 20 mg · Tablet #6 NeutrolineWater for Injection 5presentations 10 mL, 20 mL presentation, 5 mL · Injection
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median5129% of comparable products
Near market median77within ±5% of median
Above market median4626% of comparable products
Lowest-price equivalents21ties included
Company median price position +0.2% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
Neuvanco concentrate for 500 mgVancomycin · Injection · 10's PKR 113.68/vial/unit-91.0% vs market median Neupencilin 250 mgPenicillamine · Tablet · 10's PKR 29.92/tablet-70.0% vs market median Dianext MR 60 mgGliclazide · Modified-release tablet · 20's PKR 11.47/tablet-65.3% vs market median Dermacort-B w/w 0.1 %Betamethasone · Cream · 15gm PKR 2.00/g-60.3% vs market median Silvia 1 %Sulphadiazine · Cream · 500gm PKR 1.60/g-59.9% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Pharmasol (Pvt) Ltd.257 products · 102 generics 51shared generics M/s. Genix Pharma (Pvt) Ltd.297 products · 97 generics 50shared generics Bio-Labs(Pvt) Ltd236 products · 82 generics 47shared generics Mediate Pharmaceutical Pvt Ltd236 products · 90 generics 46shared generics Nabiqasim Industries (Pvt) Ltd.,365 products · 118 generics 45shared generics Valor Pharmaceuticals219 products · 97 generics 44shared generics
Regulatory & price activity

Observed database signals

Indexed registration numbers188Distinct registrations among indexed, published, presentation-validated products only
Verified price observations210
Products with a verified price210
Products with multiple price observations0
Source records with multiple versions209
Latest portfolio source check22 Sep 2026
Latest effective price date4 Aug 2026
Latest source observation25 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

194 unique registration(s) · 93 indexed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Intelligence filter: Therapeutic areaAnti-infectives Clear intelligence filters
Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Acrid Doxycycline 50 mg Capsule 56's 064904 PKR 205.06 PKR 3.66/capsule Near median
Acrid Doxycycline 100 mg Capsule 5x10's 064919 PKR 398.94 PKR 7.98/capsule Near median
Affif Ciprofloxacin 200 mg IV infusion 100ml 046877 PKR 239.36 PKR 2.39/mL 12% above median
Affif Ciprofloxacin 250 mg Tablet 10's 049432 PKR 259.31 PKR 25.93/tablet Near median
Affif Ciprofloxacin 500 mg Tablet 10's 049433 PKR 428.86 PKR 42.89/tablet Near median
Affif Ciprofloxacin 125 mg/5 mL Dry suspension 60ml 071196 PKR 222.36 PKR 3.71/mL Near median
Affif Ciprofloxacin 250 mg/5 mL Dry suspension 60ml 071197 PKR 319.15 PKR 5.32/mL 5% above median
Amikaneu Amikacin 250 mg Injection 2mlx1's 042938 PKR 131.65 PKR 65.83/mL Near median
Azineu Azithromycin 250 mg Tablet 6's 049428 PKR 223.41 PKR 37.24/tablet 21% below median
Azineu Azithromycin 250 mg Tablet 10's 049428 PKR 373.01 PKR 37.30/tablet 21% below median
Azineu Azithromycin 500 mg Tablet 6's 054381 PKR 548.54 PKR 91.42/tablet 8% above median
Azineu Azithromycin 200 mg/5 mL Dry suspension 15ml 054382 PKR 329.13 PKR 21.94/mL Near median
Aziro Azithromycin 500 mg Capsule 3's 064927 PKR 249.34 PKR 83.11/capsule Near median
Aziro 250 Azithromycin 250 mg Capsule 10's 064926 PKR 508.65 PKR 50.87/capsule Near median
Bazole Albendazole 100 mg Suspension 10ml 038874 PKR 31.92 PKR 3.19/mL No comparator
Capmox Moxifloxacin 400 mg Capsule 5's 064930 PKR 947.48 PKR 189.50/capsule No comparator
Claromy Clarithromycin 250 mg Tablet 10's 049427 PKR 478.73 PKR 47.87/tablet Near median
Claromy Clarithromycin 250 mg/5 mL Oral suspension 60ml 071198 PKR 564.50 PKR 9.41/mL 22% below median
Claromy Clarithromycin 125 mg/5 mL Suspension 60ml 076817 PKR 444.82 PKR 7.41/mL Near median
Claromy Clarithromycin 500 mg Injection 1's 097662 PKR 456.82 PKR 456.82/vial/unit 168% above median
Doxytab Doxycycline 100 mg Tablet 10's 069446 PKR 79.79 PKR 7.98/tablet Near median
FC-Zole Dry Fluconazole 50 mg/5 mL Dry suspension 35ml 076818 PKR 418.89 PKR 11.97/mL Near median
Inovel Artemether + Lumefantrine 20 mg + 120 mg Tablet 16's 049443 PKR 638.30 PKR 39.89/tablet Near median
Inovel Artemether + Lumefantrine 40 mg + 240 mg Tablet 8's 054379 PKR 526.60 PKR 65.83/tablet Near median
Inovel Artemether 40 mg Injection 10's 054478 PKR 1,196.82 PKR 119.68/vial/unit Near median
Inovel Artemether 80 mg/mL Injection 5x1ml Amp 054479 PKR 957.45 — No comparator
Inovel Artemether 80 mg Tablet 1x6's 069417 PKR 658.25 PKR 109.71/tablet 6% above median
Inovel Artemether 80 mg Tablet 1x4's 069417 PKR 438.83 PKR 109.71/tablet 6% above median
Itraneu Itraconazole 100 mg Capsule 4's 064971 PKR 598.41 PKR 149.60/capsule Near median
Latvir Daclatasvir 60 mg Tablet 28's 099761 PKR 8,837.71 PKR 315.63/tablet Near median
Lefoxin Levofloxacin 250 mg Tablet 10's 049435 PKR 498.67 PKR 49.87/tablet Near median
Lefoxin Levofloxacin 500 mg Tablet 10's 054386 PKR 829.79 PKR 82.98/tablet Near median
Lefoxin Levofloxacin 250 mg/5 mL Suspension 60ml 074305 PKR 498.67 PKR 8.31/mL No comparator
Lefoxin Levofloxacin 125 mg/5 mL Suspension 60ml 074306 PKR 299.20 PKR 4.99/mL No comparator
Lenova Levofloxacin 250 mg Capsule 10's 064928 PKR 398.94 PKR 39.89/capsule Near median
Lenova Levofloxacin 500 mg Capsule 10's 064929 PKR 658.25 PKR 65.83/capsule Near median
Magmony MEGLUMINE ANTIMONIATE 1.5 g/5 mL (equiv. antimony 0.405 g/5 mL) Injection 5x5ml 069460 PKR 581.77 PKR 23.27/mL No comparator
Malarex Artemether + Lumefantrine 240 mg + 240 mg Capsule 8's 064909 PKR 526.60 PKR 65.83/capsule No comparator
Malarex Artemether + Lumefantrine 20 mg + 120 mg Capsule 16's 064921 PKR 638.30 PKR 39.89/capsule 6% above median
Neosofo Sofosbuvir 400 mg Tablet 28's 091870 PKR 11,704.88 PKR 418.03/tablet Near median
Neu-Q Chloroquine 250 mg Tablet 500's 106119 PKR 1,681.57 PKR 3.36/tablet 118% above median
Neu-Q Chloroquine 50 mg/5 mL Syrup 60ml 106120 PKR 19.81 PKR 0.33/mL Near median
Neuclud Entecavir 0.05 mg/mL Oral solution 210ml 091488 PKR 9,075.87 PKR 43.22/mL Near median
Neuclud Entecavir 0.05 mg/mL Oral solution 120ml 091488 PKR 5,186.21 PKR 43.22/mL Near median
Neuclud Entecavir 0.5 mg Tablet 30's 091489 PKR 9,827.87 PKR 327.60/tablet 8% below median
Neuclud Entecavir 0.5 mg Tablet 10's 091489 PKR 3,560.53 PKR 356.05/tablet Near median
Neuclud Entecavir 1 mg Tablet 30's 091490 PKR 16,378.45 PKR 545.95/tablet 8% below median
Neuclud Entecavir 1 mg Tablet 10's 091490 PKR 5,934.22 PKR 593.42/tablet Near median
Neudroxin Hydroxychloroquine 200 mg Tablet 30's 101915 PKR 524.20 PKR 17.47/tablet 21% above median
Neulexin Cephalexin 500 mg Capsule 12's 054385 PKR 320.97 PKR 26.75/capsule 13% below median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Neutro Pharma (Pvt.) Ltd — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 25, 2026, from https://medinfobase.com/company/neutro-pharma-pvt-ltd/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.